[Thyroid cancer after Chernobyl: is iodine 131 the only culprit ? Impact on clinical practice]. / Le cancer de la thyroïde après Tchernobyl: l'iode 131 seul responsable? Conséquences en termes de pratique médicale.

The large increase in the incidence of thyroid cancer among children who were mainly less than five years old at the time of the Chernobyl accident is still a major preoccupation for endocrinologists and nuclear physicians. Epidemiological studies have focused solely on iodine 131. However, past knowledge on thyroid irradiation (medical use of iodine 131, radioactive fallout on Marshall islands and the Nevada, and Hanford site releases) as well as number of recent works (about low-dose irradiation), raise question on the role of other factors. It is here shown that post-Chernobyl thyroid irradiation is complex and that all factors (iodine 131, but also short lived isotopes of iodine and external irradiation) should be considered. Finally, one need to think about some of the present medical uses of iodine 131, and especially to the treatment of hyperthyroidism in young subjects.

[Kinetics of intracolloidal iodine within the thyroid of newborn rats. Direct imagery using secondary ion mass spectrometry]. / Cinétique intracolloïdale de l'iode dans la thyroïde de rat nouveau-né. Imagerie directe par microscopie ionique analytique.

The spatiotemporal distribution of cellular uptake site of radiotoxics is essential data for microdosimetric studies. As early as 1950, the heterogeneity of iodine incorporation within the thyroid has been shown using autoradiography. The objective of this study is to describe the kinetic cellular distribution of newly organified iodine in the thyroid of newborn rats using secondary ion mass microscopy (NanoSIMS50). Ionic images obtained at high mass resolution and with a lateral resolution of about 50 nm show that the early distribution of iodine is heterogeneous from one follicle to another, from one thyrocyte to another inside the same follicle, and that this distribution varies as a function of time. The obtained kinetic profile will allow us to refine the studies concerning the aetiopathology of thyroid cancers of the Chernobyl children.

Induction of unstable and stable chromosomal aberrations by 99mTc: in-vitro and in-vivo studies.

BACKGROUND: Biological dosimetry, which determines the dose of acquired radiation by measuring radiation-induced variation of biological parameters, can help assess radiation damage in an individual. Evaluation of radiation exposure requires setting up reference curves for each type of radiation. AIM: To evaluate the potential induction of chromosome aberrations by a clinical diagnostic dose of 99mTc. METHODS: Dicentrics, rings, excess fragments, complete reciprocal translocations and incomplete reciprocal translocations were scored in peripheral blood lymphocytes from patients exposed to a 99mTc bone scintigraphy. A specific relationship between the radiation dose delivered by 99mTc and the frequency of stable and unstable chromosomal aberrations was established in vitro to estimate whole-body dose. Chromosome analysis using fluorescence plus Giemsa and fluorescence in-situ hybridization was undertaken on six patients before and after a 99mTc bone scintigraphy. Dicentrics, rings, excess fragments, and translocations were scored in blood lymphocytes after in vitro 99mTc external irradiation in order to construct dose calibration curves. RESULTS: Analysis of the in-vitro data shows that the number of both unstable and stable aberrations has a quadratic linear relationship to the dose. Our in-vivo irradiation studies showed that activities of 99mTc-hexamethylene diphosphonate (99mTc-HDP) used for bone investigations do not induce any additional unstable chromosome aberrations and translocations. The frequencies obtained did not differ significantly from background values. CONCLUSIONS: 99mTc can produce unstable and stable chromosomal aberrations in vitro. 99mTc-HDP administration does not induce supplementary chromosomal aberrations. The dose-response curves will allow a more accurate evaluation of the risk related to in-vivo administration of 99mTc labelled radiopharmaceuticals, and they can be used to assess the safe upper limit of injected activity in humans.

OEDIPE: a personalized dosimetric tool associating voxel-based models with MCNPX.

AIM: A new tool, named OEDIPE (a French acronym that stands for "Tool for Personalized Internal Dose Assessment") was developed to carry out personalized internal dosimetry calculations for nuclear medicine (for both therapeutic and diagnostic procedures) and for radiation safety (in the case of internal contamination). It was developed under the PV-Wave visual data analysis system by the Institute of Radioprotection and Nuclear Safety (IRSN) in collaboration with the French Institute of Health and Medical Research (INSERM). This software creates anthropomorphic voxel-based phantoms from computed tomography (CT) and magnetic resonance imaging (MRI) patient images through the use of a friendly graphical user interface (GUI). Several tools have been built-in to allow for image segmentation. Source data, including VOI localization and cumulated activities, are assessed by single photon emission computed tomography (SPECT) images, and the source may be specified in any number of organs either as a point source or a homogeneously distributed source. It is also possible to choose the dosimetric parameters required for the study (mean organ dose or a dose distribution). Phantom, source, and dosimetric parameters are automatically written into a file. That file is then processed by the Monte Carlo code MCNPX (LANL) to perform the actual dose calculation. RESULTS: OEDIPE can compute either the absorbed dose in each organ (in a few minutes), or the absorbed dose in each voxel of the phantom (i.e. the spatial dose distribution at a tissue level) in a few hours or more. OEDIPE automatically reads the MCNPX output file and processes results to give a list of absorbed doses in each organ or a plot of isodose curves superimposed onto the phantom. Because of the long calculation times required to compute an absorbed dose within an entire whole-body phantom at a spatial resolution of a few millimeters, modifications were made to reduce computational times to reasonable values. To illustrate this tool, results of a dosimetric study of technetium-99m labeling of a bone-scanning agent are presented. CONCLUSION: OEDIPE is a tool that can be used for patient-specific dosimetry--for example, in targeted radiotherapy--by taking into account the individual patient anatomy, including tumors.

Distribution of injected MRI contrast agents in mouse livers studied by confocal and SIMS microscopy.

OBJECTIVE: To localize magnetic resonance imaging (MRI) contrast agents injected intravenously into mouse livers. STUDY DESIGN: Parallel studies were performed on fluorescent europium and nonfluorescent, paramagnetic gadolinium and on a product combining nanoparticles of Fe and Texas Red to obtain combined information on the distribution of these molecules inside the liver. The distribution of different superparamagnetic iron oxides was also studied because the size of these new compounds is not always convenientfor microcirculation studies. RESULTS: Europium and Texas Red can be detected by confocal microscopy. Europium, iron and gadolinium can be detected by secondary ion mass spectrometry (SIMS) microscopy. Studies confirmed the complementarity of both microscopies. They also confirmed the possibility of using europium as a model of gadolinium to analyze thefate of MRI contrast agents. CONCLUSION: The methodology can be used on mice injected intravenously and analyzed by confocal and SIMS microscopy to localize MRI contrast agents inside cellular and tissue specimens of mice.